Skip to content
Charcot–Marie–Tooth Association
Donate
Research

Actio Biosciences – ABS-0871

The Phase I study is a randomized, double-blind, placebo-controlled trial evaluating the safety, tolerability, and pharmacokinetics of ABS-0871 in healthy volunteers. Pharmacokinetics refers to how a drug is absorbed, distributed, broken down, and eliminated from the body. Data from this study will inform future clinical trials in CMT2C.

Latest Project News
Project announced: March 3, 2025
Updated: August 21, 2025
Actio Biosciences

Principal Investigator

Actio Biosciences
Actio Biosciences

Therapy / Approach

Clinical Trial - Phase 1

Total CMTA-STAR Project Investment

Unknown

Active

More info

Simply CMT

  • CMTA-STAR Under the Microscope graphic titled “Reproductive Choices in CMT,” presenting a patient-friendly overview of family planning options for people living with Charcot-Marie-Tooth disease.

    Under the Microscope: Reproductive Choices in CMT

    For people living with Charcot-Marie-Tooth disease, decisions about family planning can raise complex and deeply personal questions. This Under the Microscope installment explores various reproductive options and family planning resources.